Orchard Therapeutics (ORTX)
NASDAQ: ORTX
· Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM
Orchard Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.25 | -2 | -1.09 | 0.09 | -0.34 | -0.36 | -0.51 | -1.16 | -2.01 | -3.78 | -5.92 |
PEG Ratio | -0.01 | 0.04 | 0.01 | -0.00 | 0.05 | -0.02 | -0.00 | 0.01 | 1.17 | 0.77 | 0.56 |
PS Ratio | 28.01 | 13.48 | 61.56 | 6.79 | 11.09 | 16.98 | 16.41 | 348.50 | 245.78 | n/a | n/a |
PB Ratio | 2.20 | 0.90 | 0.75 | 0.48 | 0.52 | 0.51 | 0.52 | 0.80 | 1.21 | 2.09 | 2.82 |
P/FCF Ratio | -7.35 | -3.55 | -2.54 | -3.77 | -2.86 | -2.69 | -4.53 | -4.98 | -16 | -15.09 | -21.06 |
P/OCF Ratio | -7.39 | -3.54 | -2.58 | -3.93 | -3.57 | -2.81 | -4.63 | -5.04 | -17.86 | -15.34 | -21.24 |
OCF/S Ratio | -3.79 | -3.81 | -23.85 | -1.73 | -3.1 | -6.04 | -3.55 | -69.14 | -13.76 | n/a | n/a |
Debt / Equity Ratio | 0.60 | 0.46 | 0.52 | 0.59 | 0.47 | 0.41 | 0.35 | 0.28 | 0.25 | 0.23 | 0.18 |
Quick Ratio | 2.98 | 3.03 | 3.01 | 2.72 | 3.52 | 4.20 | 5.02 | 6.39 | 6.55 | 7.39 | 6.75 |
Current Ratio | 3.12 | 3.15 | 3.12 | 2.78 | 3.57 | 4.24 | 5.06 | 6.43 | 6.59 | 7.43 | 6.77 |
Asset Turnover | 0.03 | 0.03 | 0.01 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | n/a | n/a |
Interest Coverage | -23.18 | -23.14 | -27.44 | 142.63 | -32.01 | -48.29 | -55.67 | -53.32 | -48.2 | -60.73 | -65.22 |
Return on Equity | -0.44 | -0.11 | -0.17 | 1.37 | -0.38 | -0.35 | -0.25 | -0.17 | -0.15 | -0.14 | -0.12 |
Return on Assets | -0.17 | -0.05 | -0.08 | 0.62 | -0.2 | -0.2 | -0.15 | -0.11 | -0.1 | -0.1 | -0.09 |
Return on Invested Capital | -0.13 | -0.12 | -0.15 | 0.76 | -0.13 | -0.14 | -0.15 | -0.13 | -0.1 | -0.11 | -0.1 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.72 | 0.70 | 0.70 | 1.27 | 0.72 | 0.74 | 0.72 | 1.00 | 0.81 | n/a | n/a |
Net Profit Margin | -5.6 | -1.68 | -14.08 | 19.31 | -8.23 | -11.66 | -8.02 | -75.25 | -30.57 | n/a | n/a |
Pretax Profit Margin | -5.45 | -1.68 | -14.09 | 19.33 | -8.42 | -11.71 | -8.01 | -75 | -31.53 | n/a | n/a |
Operating Profit Margin | -3.43 | -3.08 | -21.23 | 19.05 | -4.43 | -7.43 | -6.8 | -75.39 | -27.62 | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -3.43 | -2.67 | -15.91 | 19.15 | -8.19 | -11.4 | -7.76 | -72.18 | -30.41 | n/a | n/a |